The inhibition of proliferation and migration of glioma spheroids exposed to temozolomide is less than additive if combined with irradiation

Oncology Reports

Volumn 17, Issue 4, 2007, Pages 941-945

  Fehlauer, Fabian ^a,b   Muench, Martina ^a   Richter, Eckhard ^a   Rades, Dirk ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY OF HAMBURG   (Germany)

Author keywords

Glioma; Irradiation; Migration; Proliferation; Spheroids; Temodal

Indexed keywords

ALKYLATING AGENT; DACARBAZINE; DRUG DERIVATIVE; TEMOZOLOMIDE;

ARTICLE; BRAIN TUMOR; CELL CULTURE; CELL MOTION; CELL PROLIFERATION; DRUG EFFECT; GLIOMA; HUMAN; MULTICELLULAR SPHEROID; MULTIMODALITY CANCER THERAPY; RADIATION EXPOSURE;

ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; CELL MOVEMENT; CELL PROLIFERATION; COMBINED MODALITY THERAPY; DACARBAZINE; GLIOMA; HUMANS; SPHEROIDS, CELLULAR; TUMOR CELLS, CULTURED;

EID: 34249950758     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.17.4.941     Document Type: Article

References (34)

1. Gonzalez Gonzalez D and Hulshof MCCM: Neurooncology. In: Primary tumors and neurological complications of cancer. Radiotherapy. Twijnstra A, Keyser A and Ongerboer de Visser BW (eds). Elsevier, Amsterdam, pp134-158, 1993.
2. Brock CS and Bowler M: Current perspectives in gliomas. Med Oncol 14: 103-120, 1997. (Pubitemid 27405140)
3. Prados MD and Russo C: Chemotherapy of brain tumors. Semin Surg Oncol 14: 88-95, 1998. (Pubitemid 128774939)
4. De Angelis LM: Benefits of adjuvant chemotherapy in high-grade gliomas. Semin Oncol 30: 15-18, 2003.
5. O'Reilly SM, Newlands ES, Glaser MG, Rice-Edwards JM, Brampton M, Illingworth RD, Richards PG, Kennard C, Colquhoun IR and Lewis P: TZM a new oralcytotoxic chemotherapeutic agent with promising activity against primary brain tumors. Eur J Cancer 29: 940-942, 1997. (Pubitemid 23126688)
6. Bower M, Newlands ES, Bleehen NM, Brada M, Begent RJ, Calvert H, Colquhoun I, Lewis P and Brampton MH: Multicentre CRC phase II trial of TZM in recurrent or progressive high-grade glioma. Cancer Chemother Pharmacol 40: 484-488, 1997. (Pubitemid 27389289)
7. Stupp R, Dietrich PY, Ostermann Kraljevic S, Kraljevic S, Pica A, Maillard I, Maeder P, Meuli R, Janzer R, Pizzolato G, Miralbell R, Porchet F, Regli L, de Tribolet N, Mirimanoff RO and Leyvraz S: Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus TZM followed by adjuvant TZM. J Clin Oncol 20: 1375-1382, 2002. (Pubitemid 34177445)
8. Lanzetta G, Campanella C, Rozzi A, Nappa M, Costa A, Fedele F, Innocenzi G, Gagliardi FM, Salvati M, Minniti G, Frati A, Frati L and Vecchione A: TZM in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial. Anticancer Res 23: 5159-5164, 2003. (Pubitemid 38182140)
9. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E and Mirimanoff RO: European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group: Radiotherapy plus concomitant and adjuvant TZM for glioblastoma. N Engl J Med 352: 987-996, 2005.
10. De Angelis LM: Chemotherapy for brain tumors - a new beginning. N Engl J Med 352: 1036-1038, 2005.
11. Wedge SR, Porteous JK, Glaser MG, Marcus K and Newlands ES: In vitro evaluation of TZM combined with X-irradiation. Anticancer Drugs 8: 92-97, 1997. (Pubitemid 27064756)
12. van Rijn J, Heimans JJ, van der Berg J, van der Valk P and Slotman BJ: Survival of human glioma cells treated with various combinations of TZM and x-rays. Int J Radiat Oncol Biol Phys 47: 779-784, 2000. (Pubitemid 30317499)
13. Li H, Lochmuller H, Yong VW, Karpati G and Nalbantoglu J: Adenovirus-mediated wild-type p53 gene transfer and overexpression induces apoptosis of human glioma cells independent of endogenous p53 status. J Neuropathol Exp Neurol 56: 872-878, 1997. (Pubitemid 27329108)
14. Terzis AJ, Thorsen F, Heese O, Visted T, Bjerkvig R, Dahl O, Arnold H and Gundersen P: Proliferation, migration and invasion of human glioma cells exposed to paclitaxel (Taxol) in vitro. Br J Cancer 75: 1744-1752, 1997. (Pubitemid 27230698)
15. Sankar A, Thomas DG and Darling JL: Sensitivity of short-term cultures derived from human malignant glioma to the anticancer drug TZM. Anticancer Drugs 10: 179-185, 1999. (Pubitemid 29141304)
16. Hirose Y, Berger MS and Pieper RO: p53 effects both the duration of G2/M arrest and the fate of TZM-treated human glioblastoma cells. Cancer Res 61: 1957-1963, 2001. (Pubitemid 32692013)
17. Bjerkvig R, Tonnesen A, Laerum OD and Backlund EO: Multicellular tumor spheroids from human gliomas maintained in organ culture. J Neurosurg 72: 463-475, 1990. (Pubitemid 20072971)
18. Fehlauer F, Stalpers LJ, Panayiotides J, Gonzalez Gonzalez D, Kaaijk P, Leenstra S, van der Valk P and Sminia P: Effect of single dose irradiation on human glioblastoma spheroids in vitro.Oncol Rep 11: 477-485, 2004.
19. Mueller-Klieser W: Multicellular spheroids. A review on cellular aggregates in cancer research. J Cancer Res Clin Oncol 113: 101-122, 1987.
20. Sminia P, Acker H, Eikesdal HP, Kaaijk P, Kaaijk P, Enger P, Slotman B and Bjerkvig R: Oxygenation and response to irradiation of organotypic multicellular spheroids of human glioma. Anticancer Res 23: 1461-1466, 2003. (Pubitemid 36754115)
21. Gunther W, Pawlak E, Damasceno R, Arnold H and Terzis AJ: TZM induces apoptosis and senescence in glioma cells cultured as multicellular spheroids. Br J Cancer 88: 463-469, 2003. (Pubitemid 36308160)
22. Akslen LA, Andersen KJ and Bjerkvig R: Characteristics of human and rat glioma cells grown in a defined medium. Anticancer Res 8: 797-803, 1988.
23. Carlsson J, Nilsson K, Westermark B, Ponten J, Sundstrom C, Larsson E, Bergh J, Pahlman S, Busch C and Collins VP: Formation and growth of multicellular spheroids of human origin. Int J Cancer 31: 523-533, 1983. (Pubitemid 13058328)
24. Mueller-Klieser WF, Freyer JP and Sutherland RM: Influence of glucose and oxygen supply conditions on the oxygenation of multicellular spheroids. Br J Cancer 53: 345-253, 1986.
25. Sutherland R, Freyer J, Mueller-Klieser W, Wilson R, Heacock C, Sciandra J and Sordat B: Cellular growth and metabolic adaptations to nutrient stress environments in tumor microregions. Int J Radiat Oncol Biol Phys 12: 611-615, 1986. (Pubitemid 16081623)
26. Gliemroth J, Feyerabend T, Gerlach C, Arnold H and Terzis AJ: Proliferation, migration, and invasion of human glioma cells exposed to fractionated radiotherapy in vitro. Neurosurg Rev 26: 198-205, 2003. (Pubitemid 36835039)
27. Kim HK, Lin CC, Parker D, Lim J, Likhari P, Statkevich P, Marco A and Nomeir AA: High-performance liquid chromatographic determination and stability of 5-(3-methyltriazen-1-yl)-imidazo-4-carboximide, the biologically active product of the antitumor agent TZM, in human plasma. J Chromatogr B Biomed Sci Appl 703: 225-233, 1997. (Pubitemid 28011262)
28. Sutherland RM: Cell and environment interactions in tumor microregions: the multicell spheroid model. Science 240: 177-184, 1988.
29. Kunz-Schughart LA: Multicellular tumor spheroids: intermediates between monolayer culture and in vivo tumor. Cell Biol Int 23: 157-161, 1999.
30. Santini MT, Rainaldi G and Indovina PL: Multicellular humour spheroids in radiation biology. Int J Radiat Biol 75: 787-799, 1999. (Pubitemid 29336555)
31. Walenta S, Doetsch J, Mueller-Klieser W and Kunz-Schughart LA: Metabolic imaging in multicellular spheroids of oncogene-transfected fibroblasts. J Histochem Cytochem 48: 509-522, 2000. (Pubitemid 30210355)
32. Mahesparan R, Tysnes BB, Read TA, Enger PO, Bjerkvig R and Lund-Johansen M: Extracellular matrix-induced cell migration from glioblastoma biopsy specimens in vitro. Acta Neuropathol 97: 231-239, 1999. (Pubitemid 29137271)
33. Gliemroth J, Zulewski H, Arnold H and Terzis AJ: Migration, proliferation, and invasion of human glioma cells following treatment with simvastatin. Neurosurg Rev 26: 117-124, 2003. (Pubitemid 36735735)
34. Bobola MS, Silber JR, Ellenbogen RG, Geyer JR, Blank A and Goff RD: O6-methylguanine-DNA methyltransferase, O6-benzylguanine, and resistance to clinical alkylators in pediatric primary brain tumor cell lines. Clin Cancer Res 11: 2747-2755, 2005. (Pubitemid 40569477)